Andreessen Horowitz holds final closing of third biotech fund

The California firm raised $750 million for its latest venture capital vehicle.

Fund name: AH Bio Fund III
Amount raised: $750 million
Target size: Undisclosed
Stage of fundraising: Final close
Final close date: February 2020

Andreessen Horowitz has raised $750 million for AH Bio Fund III. Capital commitments to the fund will be used to invest in early-stage biotechnology companies throughout the United States.